B.S. in Economics, University Carlos III, Madrid, Spain, 1994; Ph.D. in Health Economics, University of Barcelona, Spain, 2001
Area(s) of Specialization:
Pharmaceutical Economics and Policy; Economic Evaluation of Health Services and Programs; Cost-effectiveness of Diabetes Education and Management Interventions; Mental Health Services Evaluation
Rosa Rodriguez-Monguio PhD is an Associate Professor and Director of the Health Policy & Management Program at the University of Massachusetts, Amherst School of Public Health and Health Sciences. Through her research, Dr. Rodriguez-Monguio advances and applies a variety of quantitative methods to study equity in access to health care services and pharmaceuticals, and the efficiency in the provision of health care services and products. Dr. Rodriguez-Monguio 's current research interests are in the areas of cost-effectiveness of healthcare services and programs including community-based diabetes behavioral interventions, assessment of the Medicaid provisions and mental health services evaluation, and the safety of drugs and medical devices. Dr. Rodriguez-Monguio's research also examines the impact of intellectual property regulation, the FDA regulation and policy, and reimbursement mechanisms on pharmaceutical prices and utilization.
Seoane E, Rodriguez-Monguio R. Hansen R. Interchangeability, Safety and Efficacy of Modified Release Drug Formulations in the US: The Case of Opioid and Other Nervous System Drugs. Clinical Drug Investigation. In press.
Qureshi Z, Haider MR, Wooten NR, Ball K, Rodriguez-Monguio R, Horner R. Bennett C. Opioid Prescription trends in the U.S.: Evidence from the National Ambulatory Medical Care Survey (NAMCS) Data 2006-2010. Substance Abuse. In press.
Okunna N, Rodriguez-Monguio R, Smelson D, Volberg R. An evaluation of substance abuse, mental health disorders, and gambling correlations: An opportunity for early public health interventions. International Journal of Mental Health & Addiction. In press.
Rodriguez-Monguio R, and Seoane E. Potentially inappropriate antipsychotic use in a nationally representative US nursing homes sample: A safety concern. Journal of Pharmaceutical Health Services Research, 2014, 5(4):215-223
Rodriguez-Monguio R, Spielberger K, Seoane E. Examination of risk evaluation and mitigation strategies and drug safety in the US. Res Social Adm Pharm. 2014; 10(1):232-238
Outterson K, Powers JH, Seoane E, Rodriguez-Monguio R, Kesselheim A. Approval and Withdrawal of New Antibiotics and Other Antiinfectives in the U.S., 1980-2009. Journal of Law, Medicine & Ethics, 2013;41(3):688-696.